Harvard Bio Q2 Revenues Drop 3.3 Percent, Net Loss Surges on Charges

Aug 09, 2005

NEW YORK, Aug. 9 (GenomeWeb News) - Harvard Bioscience, which recently announced that it would divest its capital equipment business, today reported second quarter revenue of $21.7 million, a 3.3 percent drop from revenue of $22.5 million in last year's second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Who Are You?

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

'Problematic'

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Republicans Take on Peer Review

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

This Week in Science

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

Main menu